Skip to main content

Drugs

Ausgabe 15/2023

Inhalt (10 Artikel)

Open Access Review Article

Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options

Vikas Garg, Amit M. Oza

Open Access Review Article

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney

Open Access Systematic Review

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Simona Lattanzi, Eugen Trinka, Emilio Russo, Cinzia Del Giovane, Sara Matricardi, Stefano Meletti, Pasquale Striano, Payam Tabaee Damavandi, Mauro Silvestrini, Francesco Brigo

Adis Drug Evaluation

Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

Tina Nie, Young-A Heo, Matt Shirley

AdisInsight Report

Befotertinib: First Approval

Hannah A. Blair

AdisInsight Report

Talquetamab: First Approval

Susan J. Keam

AdisInsight Report

Avacincaptad Pegol: First Approval

Connie Kang

Open Access Correction

Correction to: Ritlecitinib: First Approval

Hannah A. Blair

Aktuelle Ausgaben